Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments

Exelixis Inc. (EXEL, Financial) is a pharmaceutical company headquartered in Alameda, California that focuses on developing medicines to treat patients with various types of cancer. Investment thesis In recent years, the company's management has continued to delight investors with significant growth in its commercial business and expansion of its drug development pipeline, making Exelixis a leading player in the renal cell carcinoma market. The first investment thesis we highlight is the detailed results of ...